Search Results
Site Search
Patients with Blood Cancer Precursor at Risk of Developing Cancer Even after 30 Years - Insights
Patients with monoclonal gammopathy of undetermined significance are at risk of progressing to multiple myeloma or a related cancer─even after 30 years of stability, according to findings of a study by Mayo Clinic researchers published in...
Take a deeper look at the care provided to laboratory testing specimens along their meticulous journey through Mayo Clinic Laboratories testing.
Surprises in Coagulation Testing - Insights
In this “Hot Topic,” William Nichols, M.D., presents a case study that demonstrates how pre- and postanalytic variables of the patient and blood samples can have confounding effects on the laboratory evaluation of coagulation disorders.
Staffing to Workload in Phlebotomy Areas: Indirect Effort - Insights
Mike Baisch, Principal Systems Engineer at Mayo Clinic, discusses staffing to workload in phlebotomy areas with a focus on indirect effort, which includes tasks performed that don’t involve the patient or a patient’s sample.
Frontotemporal dementia and ALS - Insights
Learn more about how detection of amyotrophic lateral sclerosis and frontotemporal dementia paved the way for gene-targeted therapies for patients.
Inflammatory Bowel Disease - Mayo Clinic Laboratories
Inflammatory bowel disease (IBD) is typically classified as either Crohn's disease or ulcerative colitis based on clinical features, colonoscopy findings, histologic changes, and the anatomical distribution of disease. In some cases,...
At BioPharma Diagnostics, we are inspired by Mayo Clinic’s history of collaboration and breaking down barriers to change medicine. That’s why we bring Mayo Clinic expertise and quality to each project — from consulting through discovery to...
Learn more about how Mayo Clinic Laboratories helps hospital laboratories reduce costs and grow revenue.
The prostate health index or phi test reduces the need for prostate cancer biopsies by 30 percent.
Complex testing offers answers and guidance about a lifelong illness - Insights
For patients with chronic lymphocytic leukemia (CLL) — the most common leukemia in adults — advanced testing can not only provide valuable information about their disease state, but peace of mind in the face of a progressive, incurable...
Antifungal Drug Susceptibility Testing of Yeast: A Primer for Beginners - Insights
In this month’s “Hot Topic,” Nancy Wengenack, Ph.D., discusses susceptibility testing of yeast for those who are considering performing it in their laboratory, perhaps for the first time, or for those who choose to send their yeast isolates...
Gadolinium-based contrast agents (GBCAs) have revolutionized MRIs by increasing the clinical utility and detection sensitivity of these exams. GBCAs also contain gadolinium, a rare earth metal with unique chemical properties. This article...
December 2023 - Neuropathology - Insights
This "Pathways" program provides an Anatomic Pathology case that includes a history, potential answers, rationale, and relevant references. This case sub-specialty is Neuropathology.
https://news.mayocliniclabs.com/file-autoimmune-neurology-test-ordering-guide/
N EURO LO GY START ORDERING TODAY. PUT YOUR PATIENTS ON THE PATH TO THE RIGHT ANSWER. CALL 800-533-1710 OR VISIT MAYOCLINICLABS.COM/CUSTOMER-SERVICE/CONTACTS. N EURO LO GY © 2024 Mayo Foundation for Medical Education and Research. All...
Myasthenia Gravis [Test in Focus] - Insights
Christopher Klein, M.D., discusses Mayo Clinic’s updated myasthenia gravis and Lambert-Eaton syndrome testing approach. Automatic reflex to second-line testing saves time and increases sensitivity and specificity to confirm diagnosis in...
March 2023 - Clinical Biochemistry - Insights
This "Pathways" program provides a Clinical Pathology case that includes a history, potential answers, rationale, and relevant references. This case sub-specialty is Clinical Biochemistry.
The Region 4 Stork (R4S) Collaborative Project - Insights
This is a 6-part series describing the products and clinical tools of a laboratory quality improvement project called Region 4 Stork, or R4S.
The Region 4 Stork (R4S) Collaborative Project - Insights
This is a 6-part series describing the products and clinical tools of a laboratory quality improvement project called Region 4 Stork, or R4S.
The Region 4 Stork (R4S) Collaborative Project - Insights
This is a 6-part series describing the products and clinical tools of a laboratory quality improvement project called Region 4 Stork, or R4S.
The Region 4 Stork (R4S) Collaborative Project - Insights
This is a 6-part series describing the products and clinical tools of a laboratory quality improvement project called Region 4 Stork, or R4S.
The Region 4 Stork (R4S) Collaborative Project - Insights
This is a 6-part series describing the products and clinical tools of a laboratory quality improvement project called Region 4 Stork, or R4S.
The Region 4 Stork (R4S) Collaborative Project - Insights
This is a 6-part series describing the products and clinical tools of a laboratory quality improvement project called Region 4 Stork, or R4S.
The Region 4 Stork (R4S) Collaborative Project - Insights
This is a 6-part series describing the products and clinical tools of a laboratory quality improvement project called Region 4 Stork, or R4S.
Pathways Case Studies: April 2021 - Insights
This "Pathways" program provides Anatomic and Clinical Pathology cases that include a history, potential answers, rationale, and relevant references. Cases for April include the following sub-specialties: Genitourinary Pathology,...
Kootenai Health: Recapturing their market through precision coordination - Insights
Prevented from providing testing services to its community members due to a non-compete agreement with a national laboratory, Kootenai Health laboratory leaders deepened their relationship with Mayo Clinic Laboratories, receiving tactical...
Whole exome sequencing - Insights
Learn more about how whole exome sequencing at Mayo Clinic Laboratories can quickly end diagnostic testing odysseys for patients with suspected genetic disorders.
February 2021 — Dermatopathology - Insights
This "Pathways" program provides an Anatomic Pathology case that includes a history, potential answers, rationale, and relevant references. This case sub-specialty is Dermatopathology.
Clinic’s commitment to meeting the needs of every patient, from the smallest to the tallest, is central to our approach to pediatric gastroenterology testing. Developed in collaboration with Mayo Clinic’s top-ranked GI experts, our...
Groundbreaking collaborations - Insights
Together with hospitals, biopharma companies, and healthcare organizations around the globe, we are clearing the path for new technologies that will improve patient care.
A new path forward: Hussein - Insights
For a young child diagnosed with inflammatory bowel disease, an unexpected turn of events led by results of a Mayo Clinic Laboratories test freed him and his family from the bonds of frequent medical visits and expensive treatment, and...
Featuring a full menu of advanced sequencing assays, Mayo Clinic Laboratories’ genetic test offerings for early-onset gastrointestinal disorders can provide diagnostic clarity that enables customized care.
Join us at the American Academy of Neurology Annual Meeting to learn about the latest in autoimmune and genetic neurology testing.
How the COVID-19 pandemic has increased public knowledge of lab testing - Insights
While the accelerated innovation and increased access to testing that’s occurred because of the COVID-19 pandemic has been critically important to worldwide health care, so too has the crash course in laboratory testing and pathology the...
October 2022 - Cardiovascular - Insights
This "Pathways" program provides an Anatomic Pathology case that includes a history, potential answers, rationale, and relevant references. This case sub-specialty is Cardiovascular Pathology.
Robin Patel, M.D., Elected to 2-Year Term on ASM Board of Directors - Insights
Robin Patel, M.D., Chair of the Division of Clinical Microbiology and a Consultant in the Clinical Microbiology and Infectious Diseases Laboratories at Mayo Clinic, has been elected to serve a two-year term on the American Society for...
Leveraging the Laboratory 2023 - Insights
Mayo Clinic Laboratories’ Outreach Conference was held Sept. 26-27, 2023, in Chicago. “Leveraging the Laboratory: Dimensions of Outreach” provides innovative views into all aspects of health system laboratory outreach programs.
Leveraging the Laboratory 2023 - Insights
Mayo Clinic Laboratories’ Outreach Conference was held Sept. 26-27, 2023, in Chicago. “Leveraging the Laboratory: Dimensions of Outreach” provides innovative views into all aspects of health system laboratory outreach programs.
Leveraging the Laboratory 2023 - Insights
Mayo Clinic Laboratories’ Outreach Conference was held Sept. 26-27, 2023, in Chicago. “Leveraging the Laboratory: Dimensions of Outreach” provides innovative views into all aspects of health system laboratory outreach programs.
Leveraging the Laboratory 2023 - Insights
Mayo Clinic Laboratories’ Outreach Conference was held Sept. 26-27, 2023, in Chicago. “Leveraging the Laboratory: Dimensions of Outreach” provides innovative views into all aspects of health system laboratory outreach programs.
Leveraging the Laboratory 2023 - Insights
Mayo Clinic Laboratories’ Outreach Conference was held Sept. 26-27, 2023, in Chicago. “Leveraging the Laboratory: Dimensions of Outreach” provides innovative views into all aspects of health system laboratory outreach programs.
Leveraging the Laboratory 2023 - Insights
Mayo Clinic Laboratories’ Outreach Conference was held Sept. 26-27, 2023, in Chicago. “Leveraging the Laboratory: Dimensions of Outreach” provides innovative views into all aspects of health system laboratory outreach programs.
On the April 22 broadcast of Mayo Clinic Radio, co-hosts Tracy McCray and Tom Shives, M.D., spoke with Bobbi Pritt, M.D., Director of the Clinical Parasitology Laboratory, about an update on Lyme disease predictions for 2017.
Update on 2021 WHO classification of lung tumors - Insights
In this month’s “Hot Topic,” Anja Roden, M.D., discusses new entities and changes of terminology in the 2021 World Health Organization (WHO) classification of lung tumors as well as the nomenclature in small biopsies.
Industry Archives - Page 2 of 6 - Insights
Skip to Content MayoACCESS MayoLINK...
Cardiovascular Biomarkers of Atherosclerotic Risk - Insights
In this month’s “Hot Topic,” Vlad Vasile, M.D., Ph.D., reviews ceramides and their atherosclerotic risk through defining ceramides, talking about when they should be tested for and touch on the topic of ceramides in primary prevention.
April 2021 — Dermatopathology - Insights
This "Pathways" program provides an Anatomic Pathology case that includes a history, potential answers, rationale, and relevant references. This case sub-specialty is Dermatopathology.
Pathways Case Studies: April 2020 - Insights
This "Pathways" program provides Anatomic and Clinical Pathology cases that include a history, potential answers, rationale, and relevant references. Cases for April include the following sub-specialties: Gastroenterology & Surgical,...
Mayo Clinic Laboratory and Pathology Research Roundup: April 16 - Insights
This week’s Research Roundup highlights the clinical and pathological phenotype of genetic causes of focal segmental glomerulosclerosis in adults.
Transforming clinical practice and changing outcomes for brain tumor patients - Insights
The genetic variability of glioma, and its more advanced relative glioblastoma, has made genetic testing to identify biomarkers associated with prognosis and treatment effectivity an integral component of care plan development. However, the...